Daily Stock Market Report (Thur 24 July 2025) - VCP, JSE, TET, IGG, PEB, MAB1, JDG, RCH, AJB, SYS, EMR, SFR
Huge thanks to Roland and to all of you for keeping the show on the road yesterday as I was under the weather - the report had my name on it, but Roland was editing it!
Anyway, let's see what we've got today.
Wrapping it up now, thank you.
Companies Reporting
| Name (Mkt Cap) | RNS | Summary | Our view (Author) |
|---|---|---|---|
AstraZeneca (LON:AZN) (£165bn) | Statistically significant and clinically meaningful improvements for rare autoimmune disorder. | ||
Relx (LON:REL) (£71.5bn) | Reaffirms outlook. Expecting another year of strong underlying growth in rev and adj. op profit. | ||
Lloyds Banking (LON:LLOY) (£46.5bn) | 2025 guidance reaffirmed (ROTE c.13.5%). Confident in 2026 guidance (ROTE>15%). | ||
3i (LON:III) (£42.3bn) | A good start to FY26. NAV 2,711p (March 2025: 2,542p). Total return of 7% in three months. | ||
Reckitt Benckiser (LON:RKT) (£34.2bn) | Upgrading LfL net revenue guidance to above 4% in Core (prev: 3-4%). £1 billion buyback. | ||
Anglo American (LON:AAL) (£27.7bn) | Production/cost guidance for continuing biz unch. Overall copper unit cost guidance unch. | ||
Vodafone (LON:VOD) (£20.2bn) | Reiterates full year guidance. Adjusted EBITDA after leases of €11.3-11.6bn, FCF €2.4-2.6bn. | ||
BT (LON:BT.A) (£19.9bn) | On track to achieve full year guidance: revenue £4.9bn (-3%), adj. EBITDA £2.1bn, PBT £468m. | ||
Centrica (LON:CNA) (£7.69bn) | Outlook unchanged. H1 profit weighting. Usual uncertainties including weather, commodities. | ||
Airtel Africa (LON:AAF) (£6.68bn) | Customer base grew 9%. Rev +24.9% (cc). EBITDA +29.8% ($679m), profit after tax $156m. | ||
Howden Joinery (LON:HWDN) (£4.6bn) | On track with the outlook for 2025. Strong H1 close due to well executed promotions/incentives. | ||
IG group (LON:IGG) (£3.7bn) | Rev +9%, adj. PBT +17% (£535.8m). Confident re: FY26 exps for revenue and cash EPS. | GREEN (Graham holds) One of my favourite companies and favourite shares, and a large part of my personal portfolio, I’m thrilled to see it performing so well. The supportive market conditions seen over the past year can’t be expected to continue indefinitely but I have a high degree of confidence in the new CEO and support the initiatives he is pursuing. | |
ITV (LON:ITV) (£2.9bn) | SP +7% On track to deliver 2026 key financial targets. ITV Studios outlook unchanged. | ||
AJ Bell (LON:AJB) (£2.1bn) | Customer numbers +17% y/y. AUA +15%. Strong momentum underpins confidence in full year. | GREEN (Graham) [no section below] Probably one of the highest-quality listed companies in the UK, this investment platform has posted a solid update with continued impressive growth figures. Clearly their formula is working and attracting a steady stream of new customers. Net inflows show investor willingness to participate in markets more broadly, in contrast to outflows at the fund managers we cover in this report. This was a particularly favourable quarter given high volatility (prompting dealing activity) and then a rebound (boosting AUA). While it could be argued that the current earnings multiple of 21x is “up with events”, I’d like to leave our GREEN stance unchanged given the strongly positive business and share price momentum (Stocko MomentumRank 85). | |
Sigmaroc (LON:SRC) (£1.26bn) | H1 ahead of our exps. Outlook: do not expect market sentiment to improve markedly before year-end | ||
Wizz Air Holdings (LON:WIZZ) (£1.12bn) | SP -4% Q2 outlook: Load factor flat (prev: >2ppt y/y). Rationalising A321XLR program. | BLACK | |
| Vesuvius (LON:VSVS) (£962m) | Trading Statement | SP -10% Now anticipates that challenging conditions will persist. H2 performance to be similar to H1. | |
CVS (LON:CVSG) (£855m) | FY25 adj. EBITDA in line with consensus (£134m). Positioned well to deliver attractive growth. | ||
Discoverie (LON:DSCV) (£686m) | In line. Expectations for adjusted earnings for FY26 unchanged. Q1 group orders -4% (cc). | ||
Resolute Mining (LON:RSG) (£670m) | Initial estimates for Bantaco West and Bantaco South prospects, total approx. 266koz gold. | ||
M P Evans (LON:MPE) (£656m) | Harvested crops +9%, total fresh fruit bunches -3%. Crude palm oil production -2%. CPO price +13%. | ||
Boku (LON:BOKU) (£617m) | Full year rev growth ahead of exps. Adj. EBITDA in line with consensus if FX costs included. | ||
Judges Scientific (LON:JDG) (£525m) | SP -18% H1 Revenue +7%, Adj. EPS +15%, “As a result of these headwinds coupled with the aforementioned business specific issues, the Board now anticipates delivering Adjusted basic earnings per share of between 285p and 330p per ordinary share in FY25 which is below market expectations” (expectations were 367.2p). Overall organic growth was 4%, with the major weakness being North America (down 18%). | BLACK (AMBER/RED) (Graham) [no section below] I’m dismayed to see this former small-cap favourite struggling to maintain its prior standards of performance. As noted in March, when I was neutral on the stock, there have numerous reasons to be cautious on it in recent times, and the danger has now materialised in the form of a fully-fledged profit warning, caused in particular by reductions in US federal government research funding. At the midpoint, the new EPS estimate is 16% below the prior consensus estimate. Personally I’m surprised that the share price is not down by more today, given the high multiple at which it was trading. As I do still admire many aspects of this company’s track record, and it is still profitable, I think a RED stance would be overly negative. I’m therefore content to downgrade our stance on this by just one notch. | |
Wickes (LON:WIX) (£523m) | H1 Revenue +3% (1.6% LFL), Net cash £158m (24H1: £152.4m), “we remain comfortable with current consensus expectations for adjusted PBT in 2025.” | ||
Mortgage Advice Bureau (Holdings) (LON:MAB1) (£450m) | Revenue +19% to £147m, Adj. PBT +14% to £14m. “The Group continues to trade in line with the Board's expectations.” Some pull-forward to transactions by the changes to Stamp Duty relief. Refinancing is expected to accelerate in H2 2025 and 2026 as five-year deals from the post-Covid boom expire. | GREEN (Graham) [no section below] Pleased to check in on this top performer from my watchlist. The franchised mortgage network has had a strong H1 and its market share of new mortgage lending has ticked up slightly to 8.3%. After some tough years in the mortgage market, it is now showing a little more confidence and its network has increased headcount by 5% in six months. If this confidence is well-founded, we should see a nice growth spurt in the coming months. I have no reason to change my positive view: while it’s not very cheap at a P/E multiple of 16x, I think the underlying quality and short-term growth prospects do support it. If the market becomes too complacent and overprices it, I will eventually remove it from my watchlist, but I don’t think we are there currently. The founder-CEO still owns 18%. | |
Reach (LON:RCH) (£240m) | HY Revenue -3.4% to £256m, Operating Profit flat at £44.8m, EPS +6^ to 10.7p, Net Debt £26m (HY24:12.3m), interim dividend held. “Whilst July's referral volumes were impacted by Google's recent core update, we remain confident in delivering market expectations for the full year.” | AMBER/GREEN (Mark) | |
Animalcare (LON:ANCR) (£200m) | H1 Revenue +19% to £43.8m, U/L EBITDA +40% to £9.2m, Net debt £7.9m (21H1: £9.0m) | ||
City of London Investment (LON:CLIG) (£181m) | Funds under Management +5.6% to $10.8 billion as of 30 June 2025 as compared to $10.2 billion as of 30 June 2024. Final dividend for the year ended 30 June 2025 to be in line with the previous year. | ||
Aptitude Software (LON:APTD) (£164m) | “...with the deferral of some new opportunities and the significant change in GBP to USD exchange rate impacting reported revenues, Aptitude's revenues for FY 2025 are now expected to be broadly in line with the Board's expectations. As a result of the re-organisation of the business, including the benefits of cost reductions, the Board remains confident that the Group will meet its current profit expectations for FY 2025.” | ||
Treatt (LON:TET) (£149m) | Now expect revenue of between £130m and £135m and profit before tax and exceptionals (PBTE) of between £9m and £11m, lower than previous guidance. |
BLACK (AMBER) (Mark - I hold) | |
| Quartix Technologies (LON:QTX) (£118m) | Interim Results | Revenue +10% to £17.6m, EBITDA +30% to £3.7m, EPS +26% to 5.52p. “The Board is confident in the outlook for the remainder of the year and now believes that both profit and cashflow will be slightly ahead of market expectations.” | |
Jadestone Energy (LON:JSE) (£107m) | H1 2025 average production +21% to 20,368 boe/d, Operating costs -10% to $112.8m. Net debt $107.6m (31 Dec: $104.8m) excl. $62.5m liftings received in early July. 2025 production guidance is increased by 1,000 boepd to 19,500-21,500 boe/d. 2025 operating cost range is reduced by $15m to US$240-280m. | AMBER (Mark) [no section below] | |
Severfield (LON:SFR) (£103m) | Revenue -3%, U/L Op Profit -42% to £21.7m, U/L EPS -52% to 4.3p. Net debt £43.1m (FY24: £9.4m). Outlook unchanged. | AMBER/RED (Mark) [no section below] These are poor results, even on an adjusted basis. Net debt on a pre-IFRS-16 basis balloons to £43.1m from £9.4m, funding higher working capital requirements even on reduced trading. On top of this there is £30m of provisions which are mainly due to the bridge remediation work they need to carry out net of insurance payouts. The reality is that that competitor Billington (which I hold) is cheaper, more conservative financed and better run. | |
Cornish Metals (LON:CUSN) (£102m) | The first major phase of surface redevelopment at South Crofty started in early July with refurbishment of the Mine Dry building and demolition of the old Bartles Foundry buildings. Part funded by UK Government. | ||
Victoria (LON:VCP) (£84.3m) | U/L Revenue -9% to £1.115bn, U/L EBITDA - 28% to £113.7m, U/L LBT £11.5m. Net debt £897.9m, 7.9x EBITDA. “The Board expects revenue to return to a more typical H2 weighted seasonality after successive years of a contracting market, and H2 will also benefit from the ongoing self-help cost initiatives.” Refinancing has 90%+ support from bondholders. | RED (Mark) [no section below] | |
Bango (LON:BGO) (£64m) | 25H1 Revenue +5% to $25.2m, Adj. EBITDA +60% to $6.5m, Net debt $7.3m (24H1: $5.1m). “A solid performance in the first six months of the year underpins the Board's continued confidence in meeting full-year market expectations." | ||
Ondo InsurTech (LON:ONDO) (£36m) | “Under the agreement, vipHomeLink will provide the LeakBot water damage prevention system to its network of small and mid-sized U.S. insurance carriers, enabling streamlined access and complete, turnkey deployment of LeakBot programs at lower minimum volumes.” |
| |
iomart (LON:IOM) (£32m) | Revenue +13% to £143.5m, Adj. EBITDA - 9% to 34.3m, Adj. EPS - 65% to 3.4p. Net debt £101.9m (FY24: £42.3m). Dividend foregone. Outlook: “Q1 trading was in line with the Board's expectations, recognising that cost reductions are more H2 weighted. Full year effect of net churn in FY25 will impact run-rate into FY26 but Q1 has achieved positive net order bookings.” | ||
Manx Financial (LON:MFX) (£29m) | “CAM Wealth Group, a wholly owned subsidiary of the Group, has been granted regulatory permission by the UK FCA to sell and distribute general insurance products within the United Kingdom.” | ||
Mission (LON:TMG) (£23m) | H1 organic revenue of £34.5m (24H1: £35.3m). Headline operating profit before adjustments of £2.1m (24H1: £1.9m). Net bank debt c.£13.6m (24H1:£19.6m, 31 Dec: £9.5m). “...on track to deliver full year revenue targets broadly in line with expectations and at least to meet full-year headline operating profit.” | ||
Argo Blockchain (LON:ARB) (£21.8m) | Argo has not regained compliance with the minimum bid price requirement | ||
Inspiration Healthcare (LON:IHC) (£19m) | “we are confident in delivering a strong first half and meeting market expectations for the full year.” | ||
SysGroup (LON:SYS) (£16.7m) | Revenue -10% to £20.5m. Adj. EBITDA -55% to £0.9m. Adj. EPS -85% to 0.3p. Net cash £3.6m (FY24: Net debt £3.4m) after £10.6m fundraise in H1. | AMBER/RED (Mark) [no section below] | |
| Eleco (LON:ELCO) (£151m) | Trading Update | SP -6% ARR +19% y/y (£30.7m). Deferred pipelines in construction have reduced non-recurring revenues. | |
Empresaria (LON:EMR) (£12m) | H1 NFI -8% to £23.4m, but flat on a CCY-LFL basis. Net debt £16.1m (31 Dec: £15.3m). FY results are expected to be in line with the board's expectations. | PINK (AMBER/RED) (Mark) [no section below] | |
Pebble Beach Systems (LON:PEB) (£11m) | SP +56% | AMBER (Mark) A material beat together with illiquidity have driven a huge rise here. However, the beat seems to be almost entirely due to cost-cutting (including reducing new product development) making it an unsustainable source of future gains. EPS forecasts are flat but the debt is being paid down rapidly and the rating remains undemanding even after today’s rise. |
Graham's Section
IG group (LON:IGG)
Up 6% to 1120p (£3.9bn) - Results for the financial year ended May 2025 - Graham - GREEN
(At the time of publication, Graham has a long position in IGG.)
Quite pleased to see the positive reaction to this update, as IG is an important share for me (currently 13% of my portfolio).
Some highlights from these results:
Revenue +9% to £1,075m.
Adj. PBT +17% to £535.8m, margin improving from 46.2% to 49.8%. This is ahead of expectations of £523.5m.
Actual PBT +25% to £499.2m.
Net interest income is included in the revenue figure and was down 6% as rates fell.
Without that headwind, revenue growth would have been higher - “net trading revenue” was up by 12%.
Capital returns: total dividend increases to 47.2p (from 46.2p), and there’s a new £125m buyback, “subject to share price performance and other demands on capital”. The amount spent on buybacks during FY25 was £235m.
Buybacks have helped to further boost EPS: for FY25, earnings per share rose 26% to 114.1p.
Customer numbers are distorted by the acquisition of Freetrade in April. Organically, active customers increased 5%.
Freetrade “performed strongly” in FY25, with assets under administration up 38% and revenue up 22%, but I don’t see it as material yet. Revenues were £29m, with only a small portion of this being generated after the takeover.
Despite the Freetrade acquisition, IG’s sprawling empire of small businesses has been curtailed by the CEO who joined in early 2024:
Exited multiple legacy and sandbox initiatives not delivering acceptable returns, including Spectrum, Brightpool, Raydius, Bad Trader, Small Exchange and our commercial operations in South Africa.
The core product has been improved with “TopTrader” (showing the positions held by IG’s most successful traders) and with a cash crypto offering. In the US, they are trying to simplify tastytrade (the options trading platform) and broaden its appeal. Accounts can be funded with crypto “stablecoins” and the range of tradable coins has expanded from 4 to 23.
CEO comment:
"In the first year implementing our strategy, we have made good initial progress delivering on our priorities of improving our product, embedding a high-performance culture and enhancing efficiency. I am pleased that we are getting closer to our customers and accelerating product velocity which is translating into stronger customer acquisition…
Looking forward, we are confident of meeting market expectations for total revenue and cash EPS in FY26. Beyond FY26, we expect total revenue to compound in a mid-to-high single-digit percentage range per annum on an organic basis, accelerating within this range over time, with cost discipline."
Estimates: thanks to IG for posting this on their website.
I note that PBT/PAT are expected to dip in FY26, before bouncing back in FY27. EPS is more resilient, presumably due to buybacks:
Graham’s view
As Breon Corcoran says, these FY25 results have benefited from “supportive market conditions”, with plenty of hot-button issues to get people trading over the past.
But that’s one of the reasons I’ve been invested here for so long: I enjoy holding shares in a business that benefits from market turmoil, as it gives me a natural hedge against anything else I might be holding.
Nothing in these results changes my view that this is an incredibly high-quality business, with fabulous cash generation (£491m of operating cash flow), return on equity (c. 20% again), and shareholder orientation with surplus cash being delivered to us on a regular basis.
If I was to put a very sceptical hat on, I could point to tastytrade as a source of risk. For a start, the seemingly relentless bullishness in the United States may have pulled more retail traders into the market than you’d get in tempered conditions.
Secondly, the news that customers there are funding their accounts with “stablecoins” could be viewed as a red flag. The phrase “stablecoin” is itself a misnomer in my view, with a claim to stability that I don’t believe is proven.
But… I am glad to have some exposure to crypto in this way. It seems to be one of the least objectionable ways to gain exposure to this asset class. If the boom continues, tastytrade will do well. If it turns out to be “a load of old cobblers”, as some of us suspect, then hopefully the hit to IG will be limited.
I’ve been holding this share for many years. For the longest time, it traded within a familiar range, but more recently has been breaking out of this range.
I think this is deserved: even at the current higher level, it trades on a P/E multiple of only 10x.
For a market leader with, as I’ve suggested, very high quality metrics, I think it still offers great value here.
The StockRanks don’t disagree, giving it a QualityRank of 100 and a StockRank of 91 - a Super Stock.
I’ll reiterate that I think the new CEO has a terrific background, having worked in the banking industry and then for many years at Paddy Power and then Betfair. I think he instinctively understands what he is dealing with at IG.
It will come as no surprise to readers that I’m GREEN on this.
Mark's Section
Pebble Beach Systems (LON:PEB)
Up 56% to 14p - Trading Update - Mark - AMBER
It's a huge rise this morning from this microcap company and it is worth starting with a warning. The majority of the rise here occurred in the first 15 mins of trading with only around £50k worth of shares traded. Illiquidity here has certainly helped the rise. For the first three days of this week only £3k’s worth of shares traded in total. Anyone buying into this company on this rise needs to believe in the long-term future of the business, since liquidity tomorrow could be zero.
Here’s the cause of the rise:
The Group entered H2 25 with a strong order book giving the Board confidence in delivering profitability materially ahead of market expectations1 for FY 25 and into FY 26.
There’s only one broker here, Cavendish, so it is easy to quantify the impact as they say:
Upgraded forecasts reflect improved cost base visibility: adj PBT upgraded +27% to £2.4m (was £1.9mE) and adj dil EPS upgraded +27% to 1.9p (was 1.5pE) in both FY25E and FY26E
However, this material beat appears to be almost entirely driven by cost-cutting:
In January 2025, the Group announced strategic plans to focus on existing core capabilities as a broadcast solutions specialist, including a significant reduction in overhead and R&D costs under a process which commenced and concluded in H1 25.
While removing unnecessary cost is clearly a good thing for the business, it seems they have also significantly reduced investment into new products. Revenue is growing, but not at particularly impressive rates:
The Group expects to report increased revenues of c.£5.9m for the Period (H1 24: £5.3m) driven by the timing of project order intake and the continued growth in SLA revenue. Revenues in the Period comprised project revenues of c.£2.6m (H1 24: £2.2m) and recurring support revenue of c.£3.3 million (H1 24: £3.1m), both up year on year.
This makes this gain likely to be a one off. EPS forecasts are flat from FY25-26 at 1.9p. Even after today’s rise this is only a P/E of around 7, making it cheap, but perhaps not out of place if flat EPS is expected. This has always been a cheaply-rated stock because of the debt that they had so this is also good news:
At 30 June 2025 net debt was £3.3m (H1 24: £4.8m) with bank debt continuing to be paid down from the Group's improving operating cash flows. Following the strategic amendments announced in January 2025, the Group has greater certainty of cashflows and re-iterates the expectation of delivering annualised cash savings of c.£2.0m, with an expectation of moving to a net cash position during 2026.
My calculations show that this is currently on a EV/EBITDA of around 5, which again looks cheap for a software business, but again only if they can grow in other ways apart from cost-cutting.
Mark’s view
A stock with a materially ahead statement and a large one-day rise would seem to fit Ed’s criteria for a further upwards drift. However, in this case, it doesn’t meet the SR>70 criteria:
I am also a bit more cautious than usual given the illiquidity and that the gain here has come from cost cutting (including reducing new product development) rather than an unexpectedly strong top line. Balancing this is that the debt is largely being paid down through internally generated cash flow and the rating isn’t expensive. I’ll go for AMBER overall.
Treatt (LON:TET)
Down 22% to 200p - Trading Update - Mark (I hold) - BLACK/AMBER
It is another profits warning here:
Treatt has continued to face trading headwinds since the announcement of the interim results on 13 May 2025 which will affect the performance for the full year. As a result, we now expect revenue of between £130m and £135m and profit before tax and exceptionals (PBTE) of between £9m and £11m, lower than previous guidance.
They helpfully quantify this:
Previous guidance at 10 April 2025 was £146-£153m revenue and £16m-£18m PBTE
They didn’t give us a similar breakdown at the previous profits warning, and unhelpfully, we don’t have access to broker’s notes here. I always feel that when mid-caps see their share price collapse to become a small cap again, they should be forced to employ a small cap broker (or at least commission some paid for research). We are largely flying blind here.
My basic maths says they did £3.6m PBTE in H1, reporting around 4.5p EPS, so they should do 12.5p EPS for the full year and the middle of their current guidance range.
The reasons given are simply a continuation of previous trends:
· Lower demand in Heritage from sustained high citrus oil prices affecting buying patterns, and leading to reformulation. Although citrus oil prices have started to reduce more recently, this has continued to impact both short-term buying patterns in value added citrus products and citrus margins. We expect a reduction of this adverse impact as citrus oil pricing normalises.
· Consumer confidence in the US, combined with geopolitical and tariff uncertainty in the US was impacting the overall beverage market in North America. This has persisted, reflected in extended softening of demand.
After the last trading update, we got a buyback, presumably intended to balance liquidity in the stock. However, with hindsight, all they appear to have done is wasted shareholders' money buying back stock at a premium to today’s price.
The £5m share buyback was completed in May 2025. The balance sheet remains strong, and we now expect to report a low net debt position at the year-end as a result of the expected lower level of profitability for the period (compared to previous guidance of £1-3m of net cash).
This level of net debt shouldn’t worry investors as this is still a profitable business, although at reduced levels, and gearing levels will be modest compared to most companies of a similar size.
Valuation:
Based on my 12.5p EPS estimate and 200p share price the stock trades on a 16x earnings, not cheap in the current market. I have no idea what the FY26 forecasts now look like but they would be taken with a pinch of salt at this stage anyway.
What is interesting is that I make the current P/TBV 0.85 based on the H1 results. This looks low for a company that is still profitable and is a previous stock market darling that fund managers would have put in their “never-sell” quality compounders portfolio a few years ago.
The risk is that that majority of those assets are their manufacturing facilities, and inventory:
These may not provide much downside protection in a liquidation scenario, but we are a long way from even considering this. Instead, my assumption is that management will either make these assets productive again or someone else will.
Mark’s view
I’ve held my nose this morning and bought some shares below £2. While there is certainly a risk that there is a further profits warning to come, and management haven’t covered themselves in glory with a badly-time buyback, the discount to TBV suggests that there is value here. If the share price dropped much further, another larger food additives business may see the opportunity to buy the company for little more than the value of their assets. If instead management deliver on their pipeline and in a couple of years EPS is back to the 30p level that was forecast prior to these warnings, then the share price is likely to be back around the £5 mark. This makes the risk-reward look favourable to me from these levels. Roland had this as AMBER at 271p when it was last reviewed on the DSMR, with the outlook lower but the share price also lower, I am of a similar view today.
Disclaimer
This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.


47 comments
Graham wrote:
"Quite pleased to see the positive reaction to this update, as IG is an important share for me (currently 13% of my portfolio)"
Wow, Graham, that's quite a weighting to IG group (LON:IGG) you've got there. I also like IG, both as a customer and a shareholder, but there's no way I'd hold anywhere near that portfolio weighting in any business that is so prone to possible changes in the regulatory environment (just checked, currently it's just over 1% in aggregate in my combined portfolios). The majority of their income comes from selling OTC leveraged products to clients who on average lose money, as per their own warnings. That's hardly the sort of societally useful company that is never going to attract regulatory scrutiny.
Of course, your portfolio may be a smaller portion of your overall wealth - in my case 100% of my wealth apart from my primary residence is directly invested in equities, so I'm maybe naturally more cautious with diversification etc than most. However, at 13% I'd really encourage you to think hard about how you'd feel if you woke up to newspaper headlines one morning proclaiming the government's intention to imminently ban spreadbetting.
Other stocks with both good value, good returns on capital and strong balance sheets do exist. Maybe without the natural volatility hedge, but personally i'd rather hold, e.g. both IG group (LON:IGG) and Jet2 (LON:JET2) then either one in isolation (both have strong value, ROCE and balance sheets, both could be vulnerable to different external factors). JET2 is just a random example with similar financial attractions to IGG.
Haven't said that, I'm sure based on your writings over the years that you go into this eyes-wide-open, and that you do know the potential ramifications of your concentration.
Treatt (LON:TET) - certainly worth looking at this over the coming weeks. For me it was a 10-25 bagger and held it for many years before exiting. It went to a ridiculous valuation, but is fundamentally a good business. The original citrus business was very cyclical though as investors are now finding - I think this is the 3rd profit warning in 3 years. It kind of proves the point that buy and hold forever doesn't often work! I am tempted to get back in at some point, but always best to wait up to 6 months for the share price to flatten out first following a profit warning, in my view.
Edit - looking back I managed to sell a small chunk at £12.72 which was a 25-bagger - good timing for once...now down 85%!
Anyone know why Journeo (LON:JNEO) sp is falling again?
Journeo (LON:JNEO) I'm really tempted to top up but obviously don't want to if there is something folks know that you and I don't!
I can see no reason other than it is not the most liquid of stocks and yesterday's fall has tempted others to cash in on the gain made over the recent weeks. MMs now doing what MMs do. A H1 TU is due next week. I anticipate no change to current expectations. I continue to hold, but admit to top slicing a sizeable position at 432.
I am always intrigued by comments it is what MM do . What do they do ? Normally the buy at one price and sell at another. If they have stock on their books they are not going to smash the price as they would lose money when they sell their position. Please do explain if I am missing something ? Obviously if bad news comes out they will drop the price so as not to get stuffed with stock.
I agree with you - in a way. But.... who else sets the price in the market?
Also quite often now, you can only buy or sell shares, not both. Had it numerous times, try to sell shares and there is no market. Or go to buy some shares and can't.
Rusty, that is how markets work. So if your a market trader selling Tomatoes and you have none, you cannot sell. If you have loads you bought at a low price you sell them off. It really is no different with shares. If some-one wants a share, they go up. And the opposite applies.
So why can't you sell them, then? If they have no shares to sell, l can understand that. But is usually selling is more of a problem. This is not after bad news either, it often after good news.
Because they do not want the rotten apples/tomatoes at the price you want to sell at. I use limit orders and normally they then sell at the bid price, or just above when they have a buyer for said goods. I use AJ Bell and never had a problem.
They're not rotten, they're decent shares, after a good update usually. Yes they can be sold later when the price has gone down. Why have a spread but you can't trade within it?
I guess where your getting pricing from. At the end of the day it is a market, no-one has to trade. As far as I know there is no regulation to say a market maker has to buy at a price generated by a third party website/app, ie the broker. I have very few issues with AJ Bell, price comes up. When a deal is not possible at the bid price, I place limit orders. The prices we see are an indication. I think this is something investors need to fully understand. Limit orders can help with this.
What do market makers do? Explanation from one here:
The Market Maker: Part 1 - Spencer Crooks, ex Director of Market Making at Winterfloods - PIWORLD
Brian Winterflood was a true market maker back in the day when the exchange had a floor.
Charles
I’ve tried to find an interview with a MM I saw a few years ago but no luck. The MM admitted they could manipulate prices. A Google query came up with this https://www.google.com/search?...
Also, there have been numerous cases mentioned here here where stop loss orders are triggered then the price moves quickly up again.
I left the market in 1989. But if these things are happening they should be reported to the FCA.
If you use stop loss then I suggest that is a dangerous strategy. It will kick in if a price is marked down. Then due to the mark down buyers appear- no surprise there.
Dear Graham & Team, thank you for your daily comprehensive coverage of companies both large and small. I appreciate that today you are almost overwhelmed with companies reporting so I am hoping that, if tomorrow is quieter, you might be able to look at Volution Group (LON-FAN) which announced a year-end trading update this morning. You will see that there will be a slight beat to earnings per share forecasts to the end of July 2025, with full year figures scheduled to be published in early October. I have held shares in this business for five or so years, first acquired during Covid, and management always seem to under promise and over deliver. I recognise Volution shares are not cheap in multiple terms, valued at just over 20x earnings for 2025; nevertheless, I would appreciate your comments.
Kind regards
Phillip
I'd be very interested to hear views on the large telcos that have reported today - BT (LON:BT.A) and Vodafone (LON:VOD) - perhaps on a slow Friday, if there is not enough time today. They both seem to be in recovery mode and share prices have done very well recently.
Super Stocks! What the StockRanks are saying about BT and Vodafone | By Roland Head | Stockopedia
Perhaps Roland could re-visit his excellent article. Thanks!
Sound like a broken record, but Synectics (LON:SNX) down again. Maybe an Insti still reducing, very frustrating as very cheap on fundamentals/growth outlook!!
Went Ex-Div so that will be the reason for some of the drop today. But I do agree, seems to be getting into top-up territory for me again.
Busy day today!
AJ Bell (LON:AJB) What a little cracker of a company this is. High quality company that is showing excellent growth. I've never owned it on account of the valuation, but it looks like I've been wrong about not paying up.
Treatt (LON:TET) My how times change. If you go back to late 2021 it was trading at a price of 1265p and a PE of 41. The price now is 204p and the PE is 12. This company is a favourite of Lord Lee, who I think many will be familiar with.
Shares down 16.4% this morning, so Mr. Market obviously not happy with what it's seeing.
I see in the Stock Report that analysts had estimated revenues of £145m for 2025, whereas now they expected to be around £130m. The conversion of their pipeline to sales has been slower than anticipated. There repeat customer volumes are down, driven by competition and US consumer confidence. Weaker USD exchange rates had further reduced the conversion.
TET is a company that I have been keeping a eye on, and I haven't written it off as a potential buy. I suspect Graham will take a harsher line. Roland gave it an Amber back in May. Maybe Graham will downgrade it? We shall see.
IG group (LON:IGG) [Happy Holder]
Full Year Highlights:
Revenue: £1,075.9m → +9%
Net trading revenue: £942.8m → +12%
Interest income: £133.1m → –6%
Adjusted PBT: £535.8m → +17%
Statutory PBT: £499.2m → +25%
Adjusted EPS: 114.1p → +26%
Statutory EPS: 106.3p → +34%
Dividend proposed: 47.2p → +2%
New buyback planned: £125m in H1 FY26
Just some notes of companies I own and reporting ...
Howden Joinery (LON:HWDN) Revs +3.2%, EBIT +3.6%. Not exactly rocketing, but the market likes what it see. Shares up 9.5% in early trading. Good quality company still with room to grow. I like the way they report EBIT in their summary. None of this EBITDA nonsense. If there are any company directors reading: take note!
IG group (LON:IGG) Revs + 12%, EBIT +28%. Crikey. Shares up 3.5% in early trading. Good quality company on a cheap valuation.
3i (LON:III) This has been an absolute barnstormer of a share for me since I bought in Oct 2022. High quality rank score. People may grouse over the PBV given it is effectively an investment trust. Total return of 7% for the quarter. Mustn't grumble at that. Retailer Action is a major part of their portfolio (something like 2/3, which is reporting strong like-for-like sales. Market is not too impressed by all this, as shares are down 1.3% in early trading.
M P Evans (LON:MPE) No financials given, just production, which is down around 2% since last H1. Commodity prices have increased substantially though, so expect good financials when it reports. Good quality company. Just beware that palm oil prices are high, and may come down. The share price of this company has been stellar over the last 20 years. Who'd have thought that from a company that owns plantations. Share price up 1.6% in early trading.
Oops, missed this. CVS (LON:CVSG) is another company I own which is reporting. It's only a very small holding for me, though. It provides veterinary services. It seems to have a nice little niche, and growing its revenues well. I wish its interest cover was higher, though.
Mark, I hold MPE . I use Gemini AI for help with research - had this on the palm oil price "
As of July 2025, the CPO market is demonstrating significant upward momentum. The benchmark Palm Oil USD Futures (FUPOc1) contract on the Kuala Lumpur exchange is trading around US$992 per metric ton, with a 52-week range of US846.25toUS1,207.5.1 Other benchmarks reflect this strength, with prices quoted at
MYR 4,338 per tonne, representing a year-on-year increase of over 10%.2 Monthly price data from the U.S. Federal Reserve confirms this trend, with averages consistently holding above US
900/MTthroughout the first half of 2025,peaking at overUS1,067/MT in February.3
Looking forward, the price is projected to remain firm. Analysis for the third quarter of 2025 suggests a trading range of US930toUS1,190 per metric ton, driven by strong buying activity and limited stock availability in exporting nations.4 Longer-term forecasts support this view, with one projection estimating a price of
MYR 4,684.59 in 12 months' time, indicating expectations of sustained price strength into mid-2026."
The conclusion is that MPE is a premier investment opportunity, strong balance sheet, best in class operator.
Charles, this feels like deja vu! Only yesterday I was on Gemini researching the same thing as I then opened a position yesterday in @MPE in my SIPP. Gemini AI looks like a helpful addition to research tools we can use for quick data gathering.
wildshot- my gemini ai query was as below. I do pay for it as part of other Google components I use.:
(1) Find the current benchmark price for crude palm oil and analyze its performance over the last quarter to establish a baseline trend.
(2) Investigate the production forecasts for the next two quarters in major producing countries, primarily Indonesia and Malaysia, focusing on factors like weather patterns (El Niño/La Niña), labor availability, and crop yield estimates.
(3) Analyze the current inventory levels of palm oil in both major producing and consuming nations (like India, China, and the EU) to gauge supply tightness or surplus.
(4) Evaluate the demand outlook from key industrial sectors, including food manufacturing, oleochemicals, and biodiesel, considering global economic growth projections.
(5) Examine the price trends and supply dynamics of competing vegetable oils, such as soybean, sunflower, and rapeseed oil, and assess their potential influence on palm oil prices.
(6) Research any recent or upcoming changes in government policies, such as export levies in producing countries or import tariffs and environmental regulations (e.g., EU Deforestation Regulation) in consuming regions.
(7) Look into macroeconomic factors, including crude oil price forecasts and currency exchange rate predictions for the US Dollar, Malaysian Ringgit, and Indonesian Rupiah.
(8) Specifically for M P Evans PLC, research their recent financial reports, stock performance, production volumes, and any company-specific news or guidance.
(9) Synthesize all findings to provide a consolidated outlook on the probable price direction for palm oil over the next six months and how these market dynamics are likely to affect the prospects of M P Evans PLC.
Not on your list (I don't want to add to what is already a huge amount of work that Graham, Roland et al. already get through - well done by the way !), but Vesuvius (LON:VSVS) showed up on my watchlist with a confusingly worded negative outlook.
edit : Eleco (LON:ELCO) update as well
That's added to the table, thanks!
Director buys on the Stocko main page seems unreliable. I think the way the system works needs adjusting. What we really want to know is about recent Director buys/sells. For example today the Vodafone (LON:VOD) indicator is a wall of red, but if you go inside you see the last six director actions have all been buys. So I never trust the red/green indicator for this part of the page. Others may have found the same.
Another busy day for announcements. Commiserations to holders of Treatt (LON:TET) where another PW follows that of April.
At the other end of the scale Pebble Beach Systems (LON:PEB) expects to be "materially ahead". Cavendish https://www.cavendish.com/rese... has a note raising eps for the current year from 1.5 to 1.9p. PEB was the only part to survive the collapse of Vislink some years ago and inherited a massive debt from that. Today it expects to be cash positive in 2026.
Another crowd favourite, Judges Scientific (LON:JDG) , seems to be getting more accident prone too. Could take quite a hit on today's warning with such a high rating. Fortunately I don't hold this one.
What an earth is going on at Treatt (LON:TET) ? Today's update is a shocker for a business that supposedly operates in a high growth attractive niche market. All that investment in new facilities in both the UK and US and business is walking out the door rather than growing. No wonder the long mooted bid has never materialised. I hold - unfortunately!
That's the problem, I don't think they do have a niche. Lots of other companies creating cheap artificial flavourings so plenty of competition out there.
They may have a niche, but as the prices increase it appears that their customers are able to reformulate away from that niche.
Operational gearing in reverse when they've just expanded their facilities is not proving to be a pleasant ride.
This is another lesson for me on 'buy and hold'. I've watched this one skyrocket and come back down to earth!
Who is the competition that is winning the business? What are Treat mgt doing about it?
"What are Treatt (LON:TET) mgt doing about it?"
It's a very good question and I suspect, the root cause of the problems - poor management. Certainly their forecasting has been woeful.
This looks a company in need of the Harwood magic - I won't be surprised to see them pop up sometime soon, kick the board out, install new management and start a One Treatt rationalisation and turnaround strategy.
I think you are right, lets hope Harwood cast their slider-rule over them
For me on Treatt (LON:TET) , very clear they are facing existential threat at the moment:
On the beverages side... similar searches for their core markets like healthy soda, citrus seltzers, flavored water, botanical mixers, etc.... all show flat YoY or growth YoY trends in the USA. So them seeing "soft demand" and blaming on geopolitical things is probably not true. Just them losing market share...
They will probably survive. But its a question of what is the new baseline market share/sales and the baseline operating margin?
Treatt (LON:TET) - interesting analysis on Treatt, The Boon Fund. Mabe they are being hit by a cyclical downturn and loss of market share. This comment "Lower repeat customer volumes, driven by competitive pressures" is worrying. It does possibly indicate that their moat isn't as wide as previously thought!
Are you planning to cover Quartix Technologies (LON:QTX) today? I can't see it in the table - high stock rank, ahead of expectations
That has been added to the table, cheers!
thanks Graham